Modeling prenatal opioid exposure in animals: Current findings and future directions
- PMID: 28965857
- PMCID: PMC5649358
- DOI: 10.1016/j.yfrne.2017.09.001
Modeling prenatal opioid exposure in animals: Current findings and future directions
Abstract
The past decade has seen a drastic rise in the number of infants exposed to opioids in utero. It is unclear what lasting effect this exposure may have on these children. Animal models of prenatal opioid exposure may provide insight into potential areas of vulnerability. The present review summarizes the findings across animal models of prenatal opioid exposure, including exposure to morphine, methadone, buprenorphine, and oxycodone. Details regarding the drug, doses, and duration of treatment, as well as key findings, are summarized in tables with associated references. Finally, significant gaps in the current preclinical literature and future directions are discussed.
Keywords: Buprenorphine; Development; HPA; Methadone; Morphine; Mu receptor; Oxycodone; Postnatal; Transgenerational.
Copyright © 2017 Elsevier Inc. All rights reserved.
Figures
References
-
- Ahmadalipour A, Sadeghzadeh J, Vafaei AA, Bandegi AR, Mohammadkhani R, Rashidy-Pour A. Effects of environmental enrichment on behavioral deficits and alterations in hippocampal BDNF induced by prenatal exposure to morphine in juvenile rats. Neuroscience. 2015;305:372–383. - PubMed
-
- Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984;7:309–338. - PubMed
-
- Basheer R, Yang J, Tempel A. Chronic prenatal morphine treatment decreases G alpha s mRNA levels in neonatal frontal cortex. Brain Res Dev Brain Res. 1992;70(1):145–148. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
